propranolol has been researched along with Dilatation, Pathologic in 13 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Dilatation, Pathologic: The condition of an anatomical structure's being dilated beyond normal dimensions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the tolerability and efficacy of the investigational use of the angiotensin II receptor blocker losartan added to β-blockade (BB) to prevent progressive aortic root dilation in patients with Marfan syndrome (MFS)." | 9.17 | Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study. ( Chen, CA; Chiu, HH; Chiu, SN; Hu, FC; Lin, MT; Lu, CW; Wang, JK; Wu, MH, 2013) |
| "The nipradilol-treated and captopril-treated rats had significantly smaller LVEDVI than did the vehicle-treated rats with both moderate and large infarction (large infarct: 2." | 5.30 | Nipradilol, a new beta-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats. ( Nakamura, M; Sonoki, H; Takeshita, A, 1997) |
| "To assess the tolerability and efficacy of the investigational use of the angiotensin II receptor blocker losartan added to β-blockade (BB) to prevent progressive aortic root dilation in patients with Marfan syndrome (MFS)." | 5.17 | Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study. ( Chen, CA; Chiu, HH; Chiu, SN; Hu, FC; Lin, MT; Lu, CW; Wang, JK; Wu, MH, 2013) |
| "Propranolol has been most extensively studied and proved effective in 19 of 21 controlled trials." | 3.77 | [Beta-blockers and migraine]. ( Bousser, MG; Massiou, H, 1992) |
| "We examined the effects of the angiotensin-converting enzyme inhibitor perindopril and the beta-blocker propranolol on dilator responses of cerebral arterioles in chronic hypertension." | 3.71 | Effects of an angiotensin-converting enzyme inhibitor and a beta-blocker on cerebral arteriolar dilatation in hypertensive rats. ( Baumbach, GL; Chillon, JM, 2001) |
| "He discusses treatment of headache in relation to management of the acute attack, avoidance of trigger factors, and pharmacological and nonpharmacological prophylaxis." | 2.37 | An overview of the classification, causes, and treatment of headache. ( Ziegler, DK, 1984) |
| "A report is presented of a girl with Graves' disease, which was diagnosed at the age of 1." | 1.30 | Graves' disease associated with exophthalmos, cerebral ventricular dilatation and accelerated growth. ( Arai, H; Arisaka, O; Fujiwara, S; Hosaka, A; Tadokoro, R; Yabuta, K, 1997) |
| "The nipradilol-treated and captopril-treated rats had significantly smaller LVEDVI than did the vehicle-treated rats with both moderate and large infarction (large infarct: 2." | 1.30 | Nipradilol, a new beta-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats. ( Nakamura, M; Sonoki, H; Takeshita, A, 1997) |
| "The 3 patients in group I with aortic dissection had an aortic root diameter greater than or equal to 5." | 1.27 | Anuloaortic ectasia: a clinical and echocardiographic study. ( Fox, R; Kotler, MN; Mintz, GS; Panidis, IP; Ren, JF; Ross, J, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elshershari, H | 1 |
| Harris, C | 1 |
| Chiu, HH | 1 |
| Wu, MH | 1 |
| Wang, JK | 1 |
| Lu, CW | 1 |
| Chiu, SN | 1 |
| Chen, CA | 1 |
| Lin, MT | 1 |
| Hu, FC | 1 |
| Yetman, AT | 1 |
| Bornemeier, RA | 1 |
| McCrindle, BW | 1 |
| Ziegler, DK | 1 |
| Hintze, TH | 1 |
| Vatner, SF | 1 |
| Fox, R | 1 |
| Ren, JF | 1 |
| Panidis, IP | 1 |
| Kotler, MN | 1 |
| Mintz, GS | 1 |
| Ross, J | 1 |
| Shores, J | 1 |
| Berger, KR | 1 |
| Murphy, EA | 1 |
| Pyeritz, RE | 1 |
| Tahernia, AC | 1 |
| Arisaka, O | 1 |
| Hosaka, A | 1 |
| Arai, H | 1 |
| Fujiwara, S | 1 |
| Tadokoro, R | 1 |
| Yabuta, K | 1 |
| Sonoki, H | 1 |
| Nakamura, M | 1 |
| Takeshita, A | 1 |
| O'Brien, TP | 1 |
| Pane, MA | 1 |
| Traystman, RJ | 1 |
| Gleason, CA | 1 |
| Chillon, JM | 1 |
| Baumbach, GL | 1 |
| Massiou, H | 1 |
| Bousser, MG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Open-label, Active Control Trial to Evaluate the Effect of LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome[NCT00651235] | Phase 2 | 44 participants (Anticipated) | Interventional | 2007-02-28 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for propranolol and Dilatation, Pathologic
| Article | Year |
|---|---|
An overview of the classification, causes, and treatment of headache.
Topics: Amitriptyline; Analgesics; Antidepressive Agents, Tricyclic; Biofeedback, Psychology; Cerebrovascula | 1984 |
Cardiovascular anomalies in Marfan's syndrome: the role of echocardiography and beta-blockers.
Topics: Adolescent; Aortic Diseases; Auscultation; Child; Child, Preschool; Dilatation, Pathologic; Echocard | 1993 |
[Beta-blockers and migraine].
Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Dilatation, Pathologic; Evoked Pote | 1992 |
5 trials available for propranolol and Dilatation, Pathologic
| Article | Year |
|---|---|
Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Angiotensin II Type 1 Receptor Blockers; Aortic | 2013 |
Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aorta; Atenolol; | 2005 |
Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome.
Topics: Adolescent; Adult; Aorta; Aortic Aneurysm; Aortic Dissection; Aortic Valve Insufficiency; Dilatation | 1994 |
Cardiovascular anomalies in Marfan's syndrome: the role of echocardiography and beta-blockers.
Topics: Adolescent; Aortic Diseases; Auscultation; Child; Child, Preschool; Dilatation, Pathologic; Echocard | 1993 |
[Beta-blockers and migraine].
Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Dilatation, Pathologic; Evoked Pote | 1992 |
7 other studies available for propranolol and Dilatation, Pathologic
| Article | Year |
|---|---|
Paternal fibrillin-1 mutation transmitted to an affected son with neonatal marfan syndrome: the importance of early recognition.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Aorta; Dilatation, Pathologic; | 2014 |
Reactive dilation of large coronary arteries in conscious dogs.
Topics: Aminophylline; Animals; Arterial Occlusive Diseases; Blood Pressure; Coronary Circulation; Coronary | 1984 |
Anuloaortic ectasia: a clinical and echocardiographic study.
Topics: Adult; Aged; Aorta, Thoracic; Aortic Aneurysm; Aortic Dissection; Dilatation, Pathologic; Echocardio | 1984 |
Graves' disease associated with exophthalmos, cerebral ventricular dilatation and accelerated growth.
Topics: Adrenergic beta-Agonists; Antithyroid Agents; Brain Diseases; Cerebral Ventricles; Child, Preschool; | 1997 |
Nipradilol, a new beta-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Captopril; Dilatation, Pathologic; Heart Ventricles; Hemodynam | 1997 |
Propranolol blocks cocaine-induced cerebral vasodilation in newborn sheep.
Topics: Adrenergic beta-Antagonists; Animals; Animals, Newborn; Blood Flow Velocity; Cerebrovascular Circula | 1999 |
Effects of an angiotensin-converting enzyme inhibitor and a beta-blocker on cerebral arteriolar dilatation in hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cere | 2001 |